What do you believe is the single most important factor driving up the cost of living in Nigeria?

The Coalition for Epidemic Preparedness Innovations (CEPI) said it has invested over $250 million in Lassa fever research since 2017 for the development of a vaccine against the deadly disease.

The CEPI’s Director of Epidemiology and Data Science, Gabrielle Breugelmans, disclosed this on Wednesday at the inauguration of the Enable 1.5 cohort study in Abuja.

Enable 1.5 is a major research initiative designed to evaluate the incidence, symptoms, and co-infections of Lassa fever with malaria in West Africa.

The new research, led by the Nigeria Centre for Disease Control (NCDC), CEPI and other partners, would commence in October at designated sites in Edo, Ondo and Ebonyi states, while it is scheduled to commence in Sierra Leone and Liberia in later weeks.

“Through deeper investigations into the variations of Lassa fever symptoms and their comparison to other prevalent infections within the region, we will obtain valuable insights that can improve diagnosis, boost outbreak preparedness, and inform future vaccine development,” the statement reads in part.

• Read More